Position in JANX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$5,034,299
+$336,699 QoQ
Shares Held
362,180
+6.4% QoQ
Ownership
0.594%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in JANX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026NORTHERN TRUST CORP holds $6,613,834,361 across 418 Biotechnology names. JANX ranks #140 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,564,264 | $1,145,046,441 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
941,941 | $727,781,290 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
858,120 | $283,926,160 | |
| 4 | INSM |
INSMED Inc
|
1,294,000 | $211,594,876 | |
| 5 | RPRX |
Royalty Pharma plc
|
3,808,735 | $182,705,014 | |
| 6 | INCY |
Incyte Corp
|
1,849,726 | $174,096,208 | |
| 7 | MRNA |
Moderna, Inc.
|
2,952,041 | $149,963,680 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,403,642 | $104,234,453 |
All Filings in JANX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,034,299 | 362,180 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $4,697,600 | 340,406 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $8,654,519 | 354,113 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $7,896,547 | 341,842 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $8,078,913 | 299,219 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $16,533,151 | 308,800 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $12,107,003 | 266,498 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $8,142,283 | 194,373 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $7,604,658 | 201,983 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $2,188,940 | 204,002 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,942,264 | 192,685 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,223,131 | 187,290 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,693,648 | 139,971 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,840,217 | 139,728 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,846,367 | 136,364 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,625,846 | 133,157 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,011,141 | 140,247 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,278,716 | 115,495 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $2,529,865 | 116,961 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||